Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration, Stargardt”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07734064
What this trial is testing

A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

Who this might be right for
Stargardt DiseaseStargardt Macular DystrophyStargardt-like Macular Dystrophy
Astellas Institute for Regenerative Medicine 30
Not applicableUnknownNCT05258032
What this trial is testing

Structural and Functional Characterization of Rare Ocular Diseases

Who this might be right for
Retinitis PigmentosaStargardt Disease 1Best Disease+2 more
Barcelona Macula Foundation 50
Not applicableActive Not RecruitingNCT06591806
What this trial is testing

An Observational Study in Children and Adults With Stargardt Disease

Who this might be right for
Stargardt Disease
AAVantgarde Bio Srl 80
Not applicableEnded earlyNCT02875704
What this trial is testing

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Who this might be right for
Stargardt DiseaseDiabetic RetinopathyMacular Degeneration (Age Related)
Johns Hopkins University 77
Not applicableUnknownNCT04281732
What this trial is testing

Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision

Who this might be right for
Low VisionRetinitis PigmentosaStargardt Disease 1+3 more
Queen's University, Belfast 20
Not applicableStudy completedNCT04909398
What this trial is testing

Pupil Dynamics and Color Vision for the Detection of Eye Diseases

Who this might be right for
Retinitis PigmentosaLeber's Hereditary Optic NeuropathyStargardt Disease
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 60
Not applicableNot Yet RecruitingNCT07265895
What this trial is testing

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

Who this might be right for
Retinal DegenerationsRetinitis Pigmentosa (RP)Stargardt Disease
IRCCS San Raffaele 200
Early research (Phase 1)UnknownNCT03772938
What this trial is testing

Stem Cells Therapy in Degenerative Diseases of the Retina

Who this might be right for
Retinal DegenerationRetinitis PigmentosaAge Related Macular Degeneration+1 more
Pomeranian Medical University Szczecin 30
Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableNot Yet RecruitingNCT07298174
What this trial is testing

Wide Field OCTA in Ocular Diseases

Who this might be right for
Age - Related Macular Degeneration (AMD)Diabetic Macular EdemaDiabetic Retinopathy+13 more
IRCCS San Raffaele 200
Not applicableLooking for participantsNCT06435000
What this trial is testing

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

Who this might be right for
StargardtStargardt's DiseaseStargardt Disease+1 more
Splice Bio 75
Not applicableStudy completedNCT05904444
What this trial is testing

The Effect of Duration Between Sessions on Microperimetric Biofeedback Training in Patients With Maculopathies

Who this might be right for
Macular DegenerationLow VisionStargardt Disease
Aier Eye Hospital, Guangzhou 29
Not applicableStudy completedNCT01977846
What this trial is testing

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

Who this might be right for
Stargardt Disease
Foundation Fighting Blindness 259
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Early research (Phase 1)Looking for participantsNCT07836452
What this trial is testing

A Phase 1, First-in-Human Study of CITY-RBP4 in Healthy Volunteers and STGD1 Participants

Who this might be right for
Stargardt Disease 1STGD1Healthy Volunteers
City Therapeutics 48
Early research (Phase 1)Study completedNCT00060749
What this trial is testing

Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 22
Not applicableLooking for participantsNCT07266584
What this trial is testing

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Who this might be right for
Stargardt DiseaseRetinitis Pigmentosa (RP)Inherited Retinal Degeneration
Science Corporation 5
Not applicableStudy completedNCT06377150
What this trial is testing

ABCA4-associated Disease in Childhood and Adolescence - a Phenotype Study

Who this might be right for
Stargardt Disease
University Hospital Tuebingen 39
Not applicableLooking for participantsNCT07502664
What this trial is testing

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

Who this might be right for
Retinitis PigmentosaStargardt Macular DystrophyStargardt Disease+3 more
Ray Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07439887
What this trial is testing

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Who this might be right for
Stargardt Disease
Ray Therapeutics, Inc. 18
Next Page